Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02280460
NCT02280460TerminatedNot Applicable

Extracorporeal Membrane Oxygenation(ECMO): Optimization of Its Use

Renzo Loyaga Rendon1 site in 1 country921 target enrollmentStarted: September 2014Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
921
Locations
1
Primary Endpoint
All cause mortality
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To create a local registry for ECMO patients.

Detailed Description

To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •requiring ECMO. For the control,Patients without ECMO admited to ICU.

Exclusion Criteria

  • •Known prisoner of the state

Outcomes

Primary Outcomes

All cause mortality

Time Frame: 1 year

Secondary Outcomes

  • all cause mortality(48 hours)
  • In-house mortality(30 day)

Investigators

Sponsor
Renzo Loyaga Rendon
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Renzo Loyaga Rendon

Medical Director, Cardiovascular Research

Spectrum Health Hospitals

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
To Construct a Prognosis Prediction Model for ECMO Patients Based on Machine Learning AlgorithmsECMO
NCT06654388Zhujiang Hospital290
Recruiting
Not Applicable
Estimation of Outcome and Quality of Life in ECMO PatientsExtracorporeal Membrane Oxygenation
NCT06400797Heinrich-Heine University, Duesseldorf1,000
Recruiting
Phase 3
RECOMMEND Platform Trial
NCT06526533Australian and New Zealand Intensive Care Research Centre600
Completed
Phase 3
Extracorporeal Support for Respiratory Insufficiency (ECMO)Lung DiseasesAcute Respiratory Failure
NCT00000562National Heart, Lung, and Blood Institute (NHLBI)
Completed
Not Applicable
PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO StudyExtracorporeal Membrane Oxygenation ComplicationTransfusion Related ComplicationHemorrhageAnticoagulant-induced Bleeding
NCT03815773The Mediterranean Institute for Transplantation and Advanced Specialized Therapies656
ECMO: Optimization of Its Use | Clinical Trial